Synthetic Biology Global Market Report 2022: Extensive Applications Of Synthetic Biology Drive Sector Growth
November 08, 2022 08:43 ET
|
Research and Markets
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market Size, Share & Trends Analysis Report by Product (Enzymes, Cloning Technologies Kits), by Technology (PCR, NGS), by...
DoubleRainbow Biosciences Announces Strategic AI Collaboration with Galixir
November 07, 2022 08:10 ET
|
DoubleRainbow Biosciences
LEXINGTON, MASS., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Double Rainbow, a sustainable health care company harnessing the power of natural evolution through bioengineering to improve the quality of human...
Global Synthetic Biology Market Report 2022: High Potential Opportunities in Agriculture, Manufacturing & Medicine
November 07, 2022 04:28 ET
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Synthetic Biology Market, By Products, By Application, By Tool, By Technology & By Region- Forecast and Analysis 2022-28" report has been...
Synthetic Biology Market Size Worth $32.73 Bn by 2028 | Vantage Market Research
October 26, 2022 06:04 ET
|
Vantage Market Research
WASHINGTON, Oct. 26, 2022 (GLOBE NEWSWIRE) -- According to a report by Vantage Market Research, the Global Synthetic Biology Market was worth USD 10.11 Billion in 2021 and is expected to be worth...
Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument
October 19, 2022 09:00 ET
|
Telesis Bio
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company,...
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
October 18, 2022 06:59 ET
|
Synlogic, Inc.
Positive results include clinically meaningful Phe reductions, with a 60% response rate and 42% reduction in plasma Phe among responders across the study population Consistent, positive measures of...
Codex DNA Announces Plan to Change Corporate Name to Telesis Bio
October 12, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced a plan to change its Company name to...
Synthetic Biology Global Market Report 2022: Synthetic Genes Open up a New World of Drug Development
October 11, 2022 04:33 ET
|
Research and Markets
Dublin, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.Global Synthetic Biology...
Codex DNA weitet Anwendung der firmeneigenen Fehlerkorrekturtechnologie aus
October 04, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), ein Pionier im Bereich automatisierter Tischsysteme für die synthetische Biologie, gab heute die Markteinführung der...
Codex DNA étend l'application de la technologie exclusive de correction des erreurs
October 04, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, 04 oct. 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ : DNAY), un pionnier des systèmes de paillasse automatisés de biologie synthétique, a annoncé aujourd'hui le lancement commercial...